ENVX · Enovix
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $2.53
Updated ·
Price against the kill line
36.8% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $2.53, set on 13 November 2026. The shares are down 55.5% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $2.53, the 11 November 2026 close before the third-quarter report, which would erase the post-results fall and show the shares leading; or Enovix announcing that a smartphone customer has resumed qualification of its AI-2 cell.
Research onlyNot in the portfolio.
Key figures from the filings · Industrials
Quarter to 4 October 2026, filed 13 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 11.0
- Revenue, change on a year (%)
- +38.2
- Gross margin (%)
- 30.1
- Operating margin (%)
- −356.0
- Free cash flow, four quarters ($M)
- −129
- Net cash, cash less debt ($M)
- −128
- Enterprise value to sales (×)
- 12.0
- Free-cash-flow yield (%)
- −37.9
All filed numbers
What Enovix reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| filed | 11.0 | +38.2 | 30.1 | −356.0 |
| filed | 9.0 | +20.8 | 14.4 | −479.8 |
| filed | 7.6 | +49.1 | 20.4 | −577.6 |
| filed | 11.3 | +15.9 | 22.2 | −390.5 |
| filed | 8.0 | +85.1 | 17.5 | −587.9 |
| filed | 7.5 | +98.2 | 26.0 | −585.6 |
| Pre-tax income ($M) | −42.1 |
| Net income ($M) four quarters: −158 | −41.9 |
| Diluted shares, change on a year (%) against the quarter to 28 September 2025 | +6.2 |
| Operating cash flow ($M) | −111 |
| Capital spending ($M) | 17.7 |
| Free cash flow ($M) | −129 |
| Cash and short-term investments ($M) | 406 |
| Debt ($M) non-current long-term debt plus current debt | 534 |
| Net cash, cash less debt ($M) | −128 |
| Deferred revenue ($M) −83.8% on a year | 1.3 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 4.3 |
| Inventory ($M) | 19.8 |
| Shareholders' equity ($M) | 169 |
| Market value ($M) | 340 |
| Enterprise value, market value plus net debt ($M) | 468 |
| Enterprise value to sales (×) | 12.0 |
| Enterprise value to operating income (×) | Not meaningful |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 2.0 |
| Free-cash-flow yield (%) | −37.9 |
Short interest (FINRA, settled 15 October 2026, published 13 November 2026): 27.1% of shares outstanding sold short, 6.8 days of average trading to cover, +8.3% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $0 | $17K |
The thesis
Enovix shares are more likely to lag the S&P 500 over the next three months. On 12 November 2026 the company dropped smartphone field testing, its largest long-term market, and guided fourth-quarter sales below the third quarter's. Growth now depends on drone and smart-eyewear orders that ship from early 2027. The fourth-quarter report, expected in late February 2027, is the first to show whether those orders support the 2027 revenue guidance.
The third quarter itself was better than expected. Revenue was $11.0 million, up 38% from a year earlier and 22% from the previous quarter, and the non-GAAP gross margin reached a record 34.5% (company 8-K, 12 November 2026). The smartphone decision came with the same report. Enovix said its pre-AI-2 cells missed its latest energy-density target of more than 1,000 watt-hours per liter. The shares fell from a $2.53 close on 11 November 2026 to $1.80 on 12 November 2026, a new 52-week closing low.
At the $1.80 close, the market prices Enovix below its cash. The company reported $512.2 million of cash, equivalents, marketable securities and restricted cash at 4 October 2026, or $2.35 per share (8-K, 12 November 2026). That discount reflects continuing losses: non-GAAP free cash flow was negative $100.8 million for the first three quarters of 2026. It also reflects $232.0 million of 4.75% 2030 notes still outstanding, plus the 3.00% 2028 notes.
Bullish and bearish views on Enovix Corporation
The bull case on Enovix Corporation (ENVX), in brief: cash exceeds the market value. The bear case: smartphone path is on hold.
Bull case
- Cash exceeds the market value. Gross cash and securities of $2.35 per share at 4 October 2026 (8-K, 12 November 2026) sit above the $1.80 close of 12 November 2026, before netting out debt.
- Debt retired at a discount. After quarter end, Enovix retired $128 million face value of its 2030 notes for about $81.4 million, a 36% discount that cut debt by $46.6 million more than the cash paid (8-K, 12 November 2026).
- Drone orders are real purchase orders. Enovix received a 100,000-battery order from a multinational dual-use drone maker and a first production order for its MX1-B01 silicon-blend cell from a US drone maker, with deliveries from early 2027 (8-K, 12 November 2026).
- 2027 guidance implies doubling sales. Revenue guidance for 2027 is $65–85 million, against an estimated $36.7–37.7 million for 2026 (8-K, 12 November 2026). Management put backlog at about $37 million on the 12 November 2026 call.
- Costs are coming down. Enovix announced 220 job cuts on 5 November 2026, which it expects to save about $8.5 million a year, and a $19 million expansion to double drone battery capacity in South Korea by the second quarter of 2027.
Bear case
- Smartphone path is on hold. On 12 November 2026 Enovix said it will not proceed with smartphone field testing and that 2027 guidance assumes nominal or no smartphone revenue. On the call, management said restarting with a second customer would take roughly six to eight months.
- Sales step down next quarter. Fourth-quarter revenue guidance is $9.0–10.0 million, below the third quarter's $11.0 million, with a non-GAAP loss of $0.13–0.17 per share (8-K, 12 November 2026).
- 2027 midpoint trails estimates. The $75 million midpoint of 2027 sales guidance is below the $77.834 million consensus estimate reported alongside the 12 November 2026 release.
- Losses continue. The third-quarter GAAP net loss was $41.9 million, or $0.19 per share. Non-GAAP free cash flow was negative $33.1 million for the quarter (8-K, 12 November 2026).
- Leadership and legal overhang. The CEO is serving on an interim basis, according to SEC Form 4 filings. The chief legal officer's departure was disclosed on 4 November 2026. Block & Leviton announced an investigation of possible securities-law violations on 12 November 2026.
- Warrant supply caps rallies. The new warrants are exercisable at $3.00 and expire early if the stock trades at or above $3.30 on 20 of 30 consecutive trading days (8-K, 12 November 2026). Exercise adds shares exactly when the price recovers.
Price setup
The shares closed at $1.80 on 12 November 2026, the 52-week closing low. That is 80.4% below the 52-week intraday high of $9.19 set on 10 December 2025. The 3-month change is −58.9%, measured from a $4.39 close on 14 August 2026.
On adjusted daily closes, the last close sits well below the 50-day moving average of $2.82 and the 200-day moving average of $4.93, both as of 12 November 2026. The levels the case turns on are the $2.53 close of 11 November 2026, the last price before the third-quarter report, and the 50-day average. The shares briefly rose from $2.40 on 5 November 2026 to $2.76 on 6 November 2026 after the cost-cut and drone-order announcements. The 12 November 2026 report wiped out that gain.
Catalysts ahead
- ~18 November 2026 (est.): Distribution of warrants to shareholders, expected to trade on Nasdaq as ENVXW. Sets how many new shares can come from exercise at $3.00 and how much of the 2028 notes can be retired through the warrants.
- ~15 January 2027 (est.): First deliveries of the 100,000-battery dual-use drone order, scheduled for January 2027. Shows whether drone orders are turning into the revenue that 2027 guidance relies on.
- ~25 February 2027 (est.): Fourth-quarter 2026 report and 2027 cost outlook. Shows whether fourth-quarter sales meet the $9.0–10.0 million guidance and how much cash 2027 will consume.
What would change the view
A daily close above $2.53, the 11 November 2026 close before the third-quarter report, which would erase the post-results fall and show the shares leading; or Enovix announcing that a smartphone customer has resumed qualification of its AI-2 cell.
What it trades with
Enovix trades on its own news: technology milestones, customer orders and financing actions. Broad market moves have less effect. Its 2027 revenue now depends mostly on drone and defense demand, so purchase orders and procurement news from drone makers carry more weight than consumer-electronics cycles. The warrant distribution and note repurchases can move the share count and the debt load independently of operating results.
Notes
- Holders of record at the close on 13 November 2026 receive one warrant per four shares; the warrants are exercisable at $3.00 in cash or in 2028 notes at face value.
- The warrants expire on 28 April 2028, or earlier if the stock trades at or above $3.30 on 20 of any 30 consecutive trading days.
- Enovix has $232.0 million of 4.75% convertible notes due 2030 outstanding after its post-quarter repurchases, plus 3.00% convertible notes due 2028.
The evidence, claim by claim (8)
- Third-quarter 2026 revenue was $11.0 million, up 38% from a year earlier; non-GAAP gross margin was a record 34.5%. Enovix 8-K, third-quarter 2026 results · as of
- Enovix will not proceed with smartphone field testing after pre-AI-2 cells missed its target of more than 1,000 watt-hours per liter. Enovix 8-K, third-quarter 2026 results · as of
- Fourth-quarter 2026 revenue guidance is $9.0–10.0 million; 2027 revenue guidance is $65–85 million. Enovix 8-K, third-quarter 2026 results · as of
- Cash, equivalents, marketable securities and restricted cash were $512.2 million, or $2.35 per share, at 4 October 2026. Enovix 8-K, third-quarter 2026 results · as of
- Non-GAAP free cash flow was negative $33.1 million in the third quarter and negative $100.8 million for the year to date. Enovix 8-K, third-quarter 2026 results · as of
- Enovix retired $128 million face value of 2030 notes for about $81.4 million, leaving $232.0 million outstanding. Enovix 8-K, third-quarter 2026 results · as of
- Enovix received a 100,000-battery order from a multinational dual-use drone systems provider, with deliveries from early 2027. Enovix 8-K, third-quarter 2026 results · as of
- Enovix cut about 220 of 946 positions, which it expects to save about $8.5 million a year. Enovix 8-K, Regulation FD disclosure · as of
Sources
Related · shared themes
AVEX
AEVEX
AEVEX's core drone and maritime business now outgrows its fading Ukraine work, and a raised 2026 outlook makes the shares modestly likely…
BA
Boeing
Boeing's shares look more likely to lag the S&P 500 because 737 MAX deliveries fell to 32 in October 2026 and its airplane unit is cutting…
CACI
CACI International
CACI International is more likely to beat the S&P 500 over three months: fiscal 2027 guidance was raised on 21 October 2026 and funded…
MRCY
Mercury Systems
Mercury Systems beat fiscal first-quarter 2027 forecasts and raised its profit and cash outlook on 10 November 2026, giving the shares a…